Pfizer made $37 billion off its Covid vaccine last year, more than the GDP of 120 countries. Moderna founders made Forbes' list of richest people. Yet only 10% of people in low-income countries have been vaccinated. And Covax—the global dose-sharing initiative—is out of money.
